Creative Medical Technology Holdings, Inc. Interest Expense on Debt
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest Expense on Debt of $2.54 thousand for the 1-month period ending 2018-09-20, per its 10-Q filed 2018-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2018-11-14
- 2018-09-20: Interest Expense, Debt 1 month $2.54K.
| Period end | Interest Expense, Debt 1 month |
|---|---|
| 2018-09-20 | $2.54K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |